Form D — Lighthouse Pharmaceuticals, Inc.
0002133359-26-000001 · filed 2026-05-07
Offering
- Industry
- Other
- Exemptions
- 06b
- Total offering
- $15,206,800
- Total sold
- $15,206,800
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Lighthouse Pharmaceuticals, Inc.
- CIK
- 2133359
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 8001 REDWOOD BLVD
NOVATO, CA 94945 - Phone
- 650 488 8430
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Casey Lynch · Executive OfficerNOVATO, CA Find on LinkedIn ↗
-
Stephen Dominy · DirectorNOVATO, CA Find on LinkedIn ↗
-
Campbell Murray · DirectorNOVATO, CA Find on LinkedIn ↗
View original on SEC EDGAR.